Strontium-89 plus zoledronic acid versus zoledronic acid for patients with painful bone metastatic breast cancer.
Yamada K, Kaise H, Taguchi T, Horiguchi J, Takao S, Suzuki M, Kubota T, Miura D, Narui K, Tawaraya K, Machida Y, Akazawa K, Kohno N, Ishikawa T; JONIE Study Group.
Yamada K, et al. Among authors: kohno n.
J Bone Miner Metab. 2022 Nov;40(6):998-1006. doi: 10.1007/s00774-022-01366-y. Epub 2022 Aug 30.
J Bone Miner Metab. 2022.
PMID: 36042056
Clinical Trial.